The Technical Analyst
Select Language :
Laboratorios [ROVI.MC]

Exchange: EURONEXT Sector: Healthcare Industry: Biotechnology

Laboratorios Price, Forecast, Insider, Ratings, Fundamentals & Signals

Laboratorios is listed at the  Exchange

0.70% €86.35

America/New_York / 17 mai 2024 @ 11:35


FUNDAMENTALS
MarketCap: 4 474.67 mill
EPS: 2.58
P/E: 33.47
Earnings Date: Jul 23, 2024
SharesOutstanding: 51.82 mill
Avg Daily Volume: 0.0781 mill
RATING 2024-05-17
B
Neutral
RATINGS
Rating CashFlow: Buy
Return On Equity: Neutral
Return On Asset: Neutral
DE: Sell
P/E: Neutral
Price To Book: Strong Sell
QUARTER GROWTHS
4/221/232/233/234/231/24
Revenue
Gr.Profit
Ebit
Asset n/a
Debtn/a
PE RATIO: COMPANY / SECTOR
1.96x
Company: PE 33.47 | sector: PE 17.08
PE RATIO: COMPANY / INDUSTRY
0x
Company: PE 33.47 | industry: PE -7.48
DISCOUNTED CASH FLOW VALUE
€58.30
(-32.48%) €-28.05
Date: 2024-05-19
Expected Trading Range (DAY)

€ 84.01 - 88.69

( +/- 2.71%)
ATR Model: 14 days

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - €86.25
Forecast 2: 16:00 - €86.25
Forecast 3: 16:00 - €86.25
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price €86.35 (0.70% )
Volume 0.0385 mill
Avg. Vol. 0.0781 mill
% of Avg. Vol 49.33 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Laboratorios Farmaceuticos Rovi, S.A.

Last 12 Months

Last 12 months chart data with high, low, open and close for Laboratorios Farmaceuticos Rovi, S.A.

RSI

Intraday RSI14 chart for Laboratorios Farmaceuticos Rovi, S.A.

Last 10 Buy & Sell Signals For ROVI.MC

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Laboratorios Farmaceuticos Rovi, S.A.

ROVI.MC

Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company distributes other products that are licensed from other laboratories. Its principal products include Hibor, a low-molecular-weight heparin to prevent and treat venous thromboembolic disease; Enoxaparin biosimilar Becat, a low-molecular-weight heparin; Neparvis to treat symptomatic chronic heart failure with reduced ejection in adult patients; Absorcol, Vytorin, and Orvatez to diet in patients with hypercholesterolemia; Hirobriz Breezhaler and Ulunar Breezhaler that are long-acting bronchodilators for the maintenance treatment of chronic obstructive pulmonary diseases; Volutsa for treatment of moderate to severe storage systems symptoms and voiding symptoms associated with benign prostatic hyperplasia in men who are not responding adequately to monotherapy treatment; and Medikinet and Medicebrán to treat attention deficit hyperactivity disorder in children and teenagers. The company also markets various hospital products for imaging diagnosis, such as Iomeron and Iopamiro for computed tomography and intervention; Multihance and Prohance for magnetic resonance imaging; Sonovue for ultrasounds; and EmpowerCTA+, EmpowerMR, and CT Exprès that are contrast injection systems and compatible disposable material. It provides non-prescription pharmaceutical products; and contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, hard capsules, and sachets. The company serves wholesalers, doctors, nursing staff, pharmacists, and patients. It has a collaboration with Moderna, Inc. for manufacturing mRNA COVID-19 vaccine candidate. The company was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.

Last 10 Buy Signals

Date Signal @
YAKUSDMay 19 - 18:09515.82
DAIUSDMay 19 - 18:00$0.998
OHMUSDMay 19 - 17:4412.14
MEDIAUSDMay 19 - 17:4319.74
CTXUSDMay 19 - 17:454.37
SAVAXUSDMay 19 - 17:3940.62
NXMUSDMay 19 - 17:4067.47
BOBAUSDMay 19 - 17:400.329
SWETHUSDMay 19 - 17:383 234.26
SANTOSUSDMay 19 - 17:405.85

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.